Pre-emption Defense: Pharma Must Show Record Of Interaction With FDA
Executive Summary
The Supreme Court's ruling in Wyeth v. Levine, which limits the circumstances in which companies can claim FDA-approved labeling pre-empts state product liability suits, is going to require companies to have a detailed dialogue with FDA